`Indian pharma resilient to potential US tariffs’
India Ratings and Research (Ind-Ra) anticipates minimal credit profile impact on Indian pharma companies from potential US tariffs on pharmaceutical imports. While the US accounts ...
Latest Post
US growth rebound: Washington economy expands at 4.3% annual pace in Q3; inflation pressures persist
The US economy surged to a 4.3% annual growth rate in the third quarter, exceeding expectations due to robust consumer spending, exports, and government outlays. ...
Trade friction: China takes India’s solar and IT policies to WTO; consultations initiated
China has initiated a trade dispute against India at the World Trade Organization. The challenge targets India’s policies on solar cells, solar modules, and information ...
Top food orders 2025: What dominated Swiggy carts this year; pizza, biryani or burger? -check list
From comfort staples to regional favourites, Indians kept returning to a familiar set of cravings in 2025. Swiggy’s year-end data offers a telling glimpse into ...
Two dates, three traps: How to fix your NPS, PAN and ITR before December 31
December brings crucial financial deadlines. Ensure your NPS Scheme A is switched by the 25th to avoid unwanted changes. The 31st marks the final chance ...
Cement consolidation: Ambuja merges ACC and Orient into one platform; what the Adani Group’s scale bet means for investors
Ambuja Cements is merging ACC and Orient Cement into itself, creating a unified listed platform for enhanced operating leverage and cost synergies. This share-based transaction ...